We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Transfusable Blood to Be Made From ESCs

By LabMedica International staff writers
Posted on 07 Apr 2009
Scientists are attempting to create synthetic blood from embryonic stem cells (ESCs).

Surplus embryos used for in vitro fertilization (IVF) treatments will be screened to find the stem cells that can develop into O-negative blood, which can be transfused into virtually every patient. More...
The stem cells can then be developed into red blood cells, offering potentially an inexhaustible supply of blood for emergency situations. This will be of great significance for the military and emergency units around the world.

In the year 2008 Advanced Cell Technology (Los Angeles, CA, USA) announced that it could make a fresh supply of blood from embryonic stem cells. Scientists in the United Kingdom, Sweden, France, and Australia are also working in the field. A consortium consisting of the NHS Blood and Transplant (Bristol, UK), Scottish National Blood Transfusion Service (Edinburgh, UK), and Wellcome Trust (London, UK) is supporting the project. They believe that the new blood supply should be ready for testing in humans within three years.

Related Links:

Advanced Cell Technology
NHS Blood and Transplant
Scottish National Blood Transfusion Service
Wellcome Trust




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
Pipette
Accumax Smart Series
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.